A new therapy showed improvements over the standard treatment for relapsed B-cell lymphoma, according to a recent study.
Northwestern is part of a $170 million, multi-institution National Institutes of Health program that is the first comprehensive study to investigate precision nutrition.
Andrea Hall, PhD, a specialist microbiologist in the National Registry of Certified Microbiologists and a certified biosafety professional, is Feinberg’s new executive director for research facilities.
A new Northwestern Medicine study has found men’s scholarly productivity increased, but women physicians were submitting less during the increase in work-from-home during the pandemic.
A new study has identified naturally occurring nano-sized particles that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies.
Michael Wang, a fourth-year medical student, is the lead author of a study recently selected by the American Heart Association as one of the top heart disease and stroke research advances of 2021.
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.
A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.